Source : https://pubmed.ncbi.nlm.nih.gov/37379124/
The current systematic review synthesized available original research on objective and self-reported sleep health dimensions among adults aged 18 to 50 years in outpatient treatment for opioid use disorder (OUD)....
A systematic review of sleep health in adults with opioid use disorder (OUD) found diverse study designs, highlighting the need for more research on optimizing sleep to improve addiction outcomes.
Source : https://pubmed.ncbi.nlm.nih.gov/38991306/
The markers of ANS and cortisol responses to acute stress after TSD in healthy individuals reveal a scarcity of consistent evidence. The included studies present enough evidence that TSD induces...
Total sleep deprivation alters autonomic nervous system and cortisol responses to stress, but evidence is inconsistent. Further research is needed to clarify its bidirectional effects and underlying mechanisms in healthy adults.
Source : https://pubmed.ncbi.nlm.nih.gov/39571101/
Sleep disturbances are a significant concern in individuals with dementia, affecting their overall health and quality of life, as well as that of their family members and caregivers. Dementia, a...
This review examines dementia's interplay with comorbidities and sleep disturbances, highlighting their impact on cognitive decline, caregiver burden, and the need for integrated, evidence-based strategies to improve patient outcomes.
Sleep is essential for overall health, with emerging evidence linking sleep disorders, especially obstructive sleep apnea, to periodontal diseases such as gingivitis and periodontitis. This review examines the association between sleep quality and duration with gum health, exploring mechanisms and clinical implications for diagnosis and treatment.
Did you know? Originally developed in Switzerland, the HypoCat™ vaccine helps to reduce cat allergies by neutralizing Fel D 1, the protein most responsible for causing allergic reactions to cat dander in humans. When given to cats, the vaccine triggers their immune system to create antibodies against Fel D 1. Results from four separate studies have reported that the HypoCat™ vaccine caused no negative side effects for cats. The vaccine is projected to be available in the U.S. by the end of 2024. A similar vaccine for dogs is currently in the early stages of development.
How could vaccines like HypoCat™ revolutionize allergy treatments and improve the lives of pet owners with allergies?
How could vaccines like HypoCat™ revolutionize allergy treatments and improve the lives of pet owners with allergies?